Toll-like receptor 9 1635A/G polymorphism is associated with HIV-1 rebound after four weeks of interruption of antiretroviral therapy. Vallejo A, Molina-Pinelo S, De Felipe B, Abad-Fernandez M, et al. J Acquir Immune Defic Syndr 2020 Jul 8. doi: 10.1097/QAI.0000000000002437.

Read + Share

Amedeo Smart

Independent Medical Education

Vallejo A, Molina-Pinelo S, De Felipe B, Abad-Fernandez M, et al. Toll-like receptor 9 1635A/G polymorphism is associated with HIV-1 rebound after four weeks of interruption of antiretroviral therapy. J Acquir Immune Defic Syndr 2020 Jul 8. doi: 10.1097/QAI.0000000000002437.
PMID: 32658127